Search Results

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
lung cancer treatment
Jul 15, 2024, 21:23 | Insight
David C. Madoff: Role of irad in the diagnosis and treatment of patients with lung cancer
David C. Madoff, Section Chief, Interventional Radiology at Yale University School of Medicine, shared on…
Jul 10, 2024, 06:59 | Blog
Lucia Borriello: Our latest review on how cancer treatments impact dormant DTCs in the lung
Lucia Borriello, Assistant Professor in the Department of Cancer and Cellular Biology at Lewis Katz…
Jul 8, 2024, 10:16 | Blog
Cancer treatments can activate dormant tumor cells in the lung triggering metastasis
Iván R. González, Medical Oncologist at Comprehensive Oncology Center, Hospital Ángeles Puebla, shared a post…
Jul 7, 2024, 13:29 | Blog
Iván R. González: Recent research reveals that cancer treatments can activate dormant tumor cells in the lung
Iván R. González, Medical Oncologist at Comprehensive Oncology Center, Hospital Ángeles Puebla, shared a post…
Jun 19, 2024, 01:42 | Blog
Narjust Florez: Discussed the role of FLAURA-2 in the treatment of young patients with EGFR positive lung cancer
 Marcelo Corassa, Medical oncologist and Clinical Researcher at Portuguese Beneficence of São Paulo, shared a…
Jun 12, 2024, 03:30 | Blog
Rasha Aboelhassan: Solving debates for the treatment of stage III inoperable lung cancer is challenging
Rasha Aboelhassan shared on LinkedIn: "For decades, solving debates for the treatment of stage III…
Apr 19, 2024, 15:52 | Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 16, 2024, 14:54 | Insight
Treatment of lung cancer is changing! - Tumor Board Tuesday
Tumor Board Tuesday shared on X/Twitter: "Tumor Board Tuesday Treatment of lung cancer is changing!…
Apr 12, 2024, 11:46 | Drugs
Piotr Wysocki: Adjuvant treatment with Alectinib in resected ALK-positive non-small cell lung cancer – interim analysis results of ALINA trial published in NEJM
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University Hospital,…
Mar 6, 2024, 11:34 | Drugs
Rami Manochakian: U.S. FDA approves Amivantamab WITH CHEMOTHERAPY for 1st Line treatment of advanced non-small cell Lung Cancer with EGFR
Rami Manochakian, Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: “HOT OFF THE PRESS…
All: 842 Posts: 21 - 30
Special Coverage